Accepted: 12 June 2019
First Online: 25 July 2019
: The authors report no conflicts of interest with respect to the content of this manuscript. M.N.P. has consulted for and advised Shire, INSYS, RiverMend Health, Addiction Policy Forum, Game Day Data, the National Council on Problem Gambling, Opiant/Lightlake Therapeutics and Jazz Pharmaceuticals; has received unrestricted research support from Mohegan Sun Casino and grant support from the National Center for Responsible Gaming; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for and advised legal and gambling entities on issues related to addictions and impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has edited journals and journal sections; has given academic lectures in grand rounds, Continuing Medical Education events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. S.W.Y. is on the Board of Directors for the Connecticut Council on Problem Gambling and has received funding support from the National Center for Responsible Gaming. N.M.P. served on the American Psychiatric Association Workgroup for the DSM-5, for which travel costs were covered but she received no compensation. N.M.P. also wrote a report for the National Gambling Trust, has reviewed grants for NIH and other agencies, and has served as an expert for legal cases related to gambling and impulse control disorders. I.M.B. has received funding from the National Center for Responsible Gaming and from the Gambling Research Exchange of Ontario. The other authors report no disclosures.